Your browser doesn't support javascript.
loading
First-line induction chemotherapy with high-dose methotrexate versus teniposide in patients with newly diagnosed primary central nervous system lymphoma: a retrospective, multicenter cohort study.
Zhong, Kaili; Shi, Yanyan; Gao, Yuhuan; Zhang, Huilai; Zhang, Mingzhi; Zhang, Qiaohua; Cen, Xinan; Xue, Mei; Qin, Yan; Zhao, Yu; Zhang, Liling; Liang, Rong; Wang, Ningju; Xie, Yan; Yang, Yu; Liu, Aichun; Bao, Huizheng; Wang, Jingwen; Cao, Baoping; Zhang, Wei; Zhang, Weijing.
Afiliação
  • Zhong K; Department of Lymphoma, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. zhongkaili3443@bjsjth.cn.
  • Shi Y; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
  • Gao Y; Department of Hematology, Fourth Hospital of Hebei Medical University (Tumor Hospital of Hebei Province), Shijiazhuang, China.
  • Zhang H; Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Zhang M; Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
  • Zhang Q; Department of Oncology, Shanxi Academy of Medical Sciences & Shanxi Bethune Hospital, Shanxi Bethune Hospital affiliated to Shanxi Medical University, Taiyuan, China.
  • Cen X; Department of Hematology, Peking University First Hospital, Beijing, China.
  • Xue M; Department of Hematology, Air Force Medical Center, Beijing, China.
  • Qin Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Zhao Y; Department of Hematology, the General Hospital of PLA, Beijing, China.
  • Zhang L; Department of Lymphoma, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Liang R; Department of Hematology, Xijing Hospital, Air Force Military Medical University, Xi'an, China.
  • Wang N; Department of Medical Oncology, General Hospital of Ningxia Medical University, Yinchuan, China.
  • Xie Y; Departments of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital and Institute, Beijing, China.
  • Yang Y; Department of Medical Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Liu A; Department of Hematology and Lymphoma, Cancer hospital of Harbin Medical University, Haerbin, China.
  • Bao H; Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China.
  • Wang J; Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
  • Cao B; Department of Lymphoma, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zhang W; Department of Hematology, Peking Union Medical College Hospital, Beijing, China.
  • Zhang W; Department of Lymphoma, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. zhangweijing7132@bjsjth.cn.
BMC Cancer ; 23(1): 746, 2023 Aug 11.
Article em En | MEDLINE | ID: mdl-37568079
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Linfoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Nervoso Central / Linfoma Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China